Hangzhou Tigermed Consulting Co., Ltd. (03347.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 45.90

From 52W high−17.93%

Volume2.23M

Market capHKD 37.03B

P/E (TTM)387.4x

P/S (TTM)4.3x

Div yield0.32%

Key dataSep 18, 2026

Open

HKD 45.90

From 52W high

−17.93%

Volume

2.23M

Market cap

HKD 37.03B

ValuationView details →

P/E (Fwd)

58.1x

EV/EBITDA

19.4x

P/E (TTM)

387.4x

RSI (14)

62.6

MomentumView details →

1D Return

−0.74%

YTD Return

+6.49%

ValuationView details →

P/E (Fwd)

58.1x

P/E (TTM)

387.4x

EV/EBITDA

19.4x

EV/Sales

4.9x

P/S (TTM)

4.3x

P/B (TTM)

1.6x

ProfitabilityView details →

Gross Margin

25.85%

Net Margin

1.28%

EBITDA Margin

25.14%

ROE (TTM)

0.48%

ROA (TTM)

0.33%

Asset Turnover

0.26x

GrowthView details →

Revenue YoY

+12.10%

EPS YoY

−70.59%

FCF YoY

+79.05%

Revenue CAGR 3Y

−1.20%

EPS CAGR 3Y

−23.71%

EBITDA YoY

+235.76%

MomentumView details →

1D Return

−0.74%

YTD Return

+6.49%

1Y Return

−0.40%

RSI (14)

62.6

vs 50D SMA

+13.60%

vs 200D SMA

+10.57%

Capital & dividendView details →

Debt/Equity

0.12x

Current Ratio

2.49x

Quick Ratio

2.46x

Div Yield

0.32%

Div Rate

HKD 0.14

Div Growth 1Y

−55.41%

EarningsView details →

EPS (Actual)

−HKD 0.63

EPS Surprise

−351.80%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.38

Avg Surprise (4Q)

−351.80%

Rev Surprise

2.32%

Financials snapshotView financials →

Revenue (TTM)

7.28B

Net Income (TTM)

93.15M

Op. CF (TTM)

1.42B

Next earningsOct 22, 2026 →

Latest newsMore news →

China's Zhejiang Securities Regulatory Bureau issued warning letters and a prior notice of administrative penalty to Tigermed's actual controllers Ye Xiaoping and Cao Xiaochun over late disclosure of shareholding changes.9d ago

Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.23d ago

Similar companies

Illumina, Inc.ILMN 昭衍新药603127.SH IDEXX Laboratories, Inc.IDXX Waters CorporationWAT IQVIA Holdings Inc.IQV Agilent Technologies, Inc.A Find similar companies →

Latest newsMore news →

China's Zhejiang Securities Regulatory Bureau issued warning letters and a prior notice of administrative penalty to Tigermed's actual controllers Ye Xiaoping and Cao Xiaochun over late disclosure of shareholding changes.9d ago Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.23d ago